StockIQpro
NYSE:NRXS

Neuraxis, INC

Neuraxis, INC's revenue grew 32.9% in fiscal 2025 to $3.6M while operating margin rose to −219.4%. Free cash flow was −$6.5M, −181.1% of revenue, and the diluted share count rose 31.3%.Summary generated from Neuraxis, INC's SEC filings. Latest annual report filed Mar 19, 2026.

Revenue (FY25)$3.6M
Revenue growth+32.9%
Revenue, 5-yr CAGRn/a
Gross margin84.2%
Operating margin−219.4%
Net margin−218.5%
ROICn/a
Return on equity−285.4%
Debt / equity0.04
Free cash flow−$6.5M
FCF margin−181.1%
Share count change+31.3%

Financials

Fiscal years, $M
Item2022202320242025
Revenue3234
Operating income−3−7−7−8
Net income−5−15−8−8
Free cash flow−2−7−6−6

Recent filings

From SEC EDGAR

Peers

Electromedical & electrotherapeutic apparatus